The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

NCT00765063 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Ulcer

Interventions

DRUG: Fragmin

Sponsor

Pfizer